| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.02 |